Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New P2Y1 antagonist will facilitate further study of the receptor and its physiological role

May 21, 1998

Lilly initiates pivotal trials with SkyePharma formulation

May 20, 1998

Phytera signs R&D and marketing agreement with NeuroSearch

May 19, 1998

Biovector licenses DNA delivery technology from NIH

May 19, 1998

CombiChem achieves milestone in Roche Bioscience collaboration

May 18, 1998

Phytera and Galileo enter into collaborative agreement

May 18, 1998

Andaris granted U.S. patent for microcapsule technology

May 15, 1998

CombiChem achieves milestone in collaboration with Teijin

May 14, 1998

VP22 provides intercellular delivery of functional p53 protein

May 14, 1998

Evotec awarded German grant for drug discovery

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...